The story of Viagra presents a nuanced case for stakeholders in the drug sector. While initially a tremendous success, creating vast sums, the intellectual property expiration and the subsequent entry of off-brand https://pharma656494.blogripley.com/42572614/the-little-copyright-and-big-pharma-a-hazardous-investment